2018 cohort company ExplORer Surgical was recently acquired by Global Healthcare Exchange, which marks the third successful exit of an HTA company in the past year and a half. Learn more here.
2018 cohort company Macro-Eyes partnered with IDA Foundation to increase supply chain efficiency using data insights generated by the Macro-Eyes software. The objective is to optimize the shipping and routing of a broader range of essential health commodities to low- and middle-income countries. Learn more here.
2019 cohort company Health Note has expanded its team to include a Senior Vice President of Sales. Jamey Christensen, one of the foremost sales leaders in the HCIT space, joined the company in this position. Learn more here.
2020 cohort company nView Medical received FDA approval for their surgical navigation option (announcement here), as well as announced a partnership with Orthofix (NASDAQ: OFIX) to co-develop and market products together (announcement here).
2021 cohort company SoniVie announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the TIVUS System for renal artery denervation for the treatment of resistant hypertension. Learn more here.